MAS PAR TDM

K032826 · Medical Analysis Systems, Inc. · DIF · Oct 9, 2003 · Clinical Toxicology

Device Facts

Record IDK032826
Device NameMAS PAR TDM
ApplicantMedical Analysis Systems, Inc.
Product CodeDIF · Clinical Toxicology
Decision DateOct 9, 2003
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.3280
Device ClassClass 1

Indications for Use

The MAS® PAR TDM is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Include PAR TDM with patient serum specimens when assaying for any of the listed constituents. Assay values are provided for the specific systems listed. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument.

Device Story

MAS® PAR TDM is a multi-constituent, liquid, stable, human serum-based control material. It serves as a test sample with known concentrations to monitor assay conditions in clinical laboratories. Clinicians or laboratory technicians include the control alongside patient serum specimens during TDM assays. By comparing observed values against provided expected ranges, users verify the consistent performance of reagents and analytical instruments. This process ensures the accuracy and reliability of patient test results, facilitating appropriate clinical decision-making regarding therapeutic drug dosing.

Clinical Evidence

No clinical data; bench testing only.

Technological Characteristics

Liquid, human serum-based control material. Multi-constituent formulation. Designed for use with clinical laboratory instrumentation for therapeutic drug monitoring. Stable, ready-to-use form factor.

Indications for Use

Indicated for use as a quality control material for monitoring assay performance in clinical laboratory determinations of therapeutic drug monitoring (TDM) constituents in patient serum specimens.

Regulatory Classification

Identification

A clinical toxicology control material is a device intended to provide an estimation of the precision of a device test system and to detect and monitor systematic deviations from accuracy resulting from reagent or instrument defects. This generic type of device includes various single, and multi-analyte control materials.

Submission Summary (Full Text)

{0} 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE ONLY TEMPLATE A. 510(k) Number: B. Analyte: Control materials for: Acetaminophen, Amikacin, Amitriptyline, Caffeine, Carbamazepine, Chloramphenicol, Cocaine, Cyclosporine, Desipramine, Digoxin, Disopyramide, Estriol, Ethanol, Ethosuximide, Gentamicin, Imipramine, Lidocaine, Lithium, Methotrexate, N-Acetylprocainamide, Netilmicin, Nortryptylinr, Phenobarbital, Phenytoin, Primidone, Procainamide, Quinidine, Salicylate, Theophylline, Tobramycin, Total T3-Triidothyronine, Total T4, Tricyclic Antidepressants, TSH, Valporic Acid, and Vancomycin. C. Type of Test: NA D. Applicant: Medical Analysis Systems Inc. E. Proprietary and Established Names: MAS PAR TDM Liquid Assayed Therapeutic Drug Control F. Regulatory Information: 1. Regulation section: 21 CFR § 862.3280, Clinical toxicology control material 2. Classification: Class I 3. Product Code: DIF 4. Panel: Toxicology (91) G. Intended Use: 1. Intended Use(s): Refer to the Indications for Use. 2. Indication(s) for use: {1} Page 2 of 4 The MAS PAR TDM is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical determinations. Include PAR TDM with patient serum specimens when assaying for any of the listed constituents. Assay values are provided for the specific systems listed. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument. 3. Special condition for use statement(s): None 4. Special instrument requirements: None H. Device Description: The MAS PAR TDM is prepared from a bovine serum base. Analyte levels are adjusted with various drugs, drug metabolites and purified chemicals. Preservatives and stabilizers are added to maintain product integrity. The product will sold in separate kits of Level 1, Level 2, and Level 3 as well as a sample pack containing one vial each of all three levels. I. Substantial Equivalence Information: 1. Predicate device name(s): MAS PARTDM 2. Predicate K number(s): K936166 3. Comparison with predicate: {2} Page 3 of 4 | Similarities | | | | --- | --- | --- | | Item | Device | Predicate | | Intended Use | The MAS PAR TDM is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical determinations. Include PAR TDM with patient serum specimens when assaying for any of the listed constituents. Assay values are provided for the specific systems listed. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument. | The MAS PAR TDM is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical determinations. Include PAR TDM with patient serum specimens when assaying for any of the listed constituents. Assay values are provided for the specific systems listed. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument. | | Product state at purchase | Liquid | Liquid | | Levels available | Three | Three | | | | | | Differences | | | | --- | --- | --- | | Item | Device | Predicate | | Shelf life | 36 months | 24 months | | | | | J. Standard/Guidance Document Referenced (if applicable): None referenced K. Test Principle: NA L. Performance Characteristics (if/when applicable): 1. Analytical performance: a. Precision/Reproducibility: NA b. Linearity/assay reportable range: NA c. Traceability (controls, calibrators, or method): {3} Page 4 of 4 All values directly assayed have been assigned with instrument and instrument manufacturer’s reagents available at the time of assay. Subsequent instrument or reagent modifications may invalidate these assigned values. d. Detection limit: NA e. Analytical specificity: NA f. Assay cut-off: NA 2. Comparison studies: a. Method comparison with predicate device: NA b. Matrix comparison: NA 3. Clinical studies: a. Clinical sensitivity: NA b. Clinical specificity: NA c. Other clinical supportive data (when a and b are not applicable): NA 4. Clinical cut-off: NA 5. Expected values/Reference range: Expected values may vary slightly with different reagent and/or methodologies used. Refer to the table included in package insert for values obtained for specific systems. Values listed are specific for this lot of control only. Good laboratory practice suggests that each laboratory establish its own parameters. M. Conclusion: I recommend that the MAS PAR TDM Liquid Assayed Therapeutic Drug Control is substantially equivalent to the legally marketed predicate device.
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...